Related references
Note: Only part of the references are listed.ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury
Kensuke Noma et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy
Jianjian Shi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction
Jens Fielitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus
Joseph M. Miano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Recent evidence for an involvement of rho-kinase in cerebral vascular disease
Sophocles Chrissobolis et al.
STROKE (2006)
The ubiquitin-proteasome system in cardiac physiology and pathology
Saul R. Powell
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Requirement of Rac1 in the development of cardiac hypertrophy
Minoru Satoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
M Hoshijima
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Physiological role of ROCKs in the cardiovascular system
K Noma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
The multifunctional roles of the four-and-a-half-LIM only protein FHL2
M Johannessen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Inhibition of rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection
Y Rikitake et al.
STROKE (2005)
ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo
D Thumkeo et al.
GENES TO CELLS (2005)
Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells
Y Rikitake et al.
CIRCULATION (2005)
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice
YX Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Muscle-specific signaling mechanism that links actin dynamics to serum response factor
K Kuwahara et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Rho-kinase is an important therapeutic target in cardiovascular medicine
H Shimokawa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes
NH Purcell et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Role of protein phosphatase type 1 in contractile functions:: Myosin phosphatase
DJ Hartshorne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF
U Philippar et al.
MOLECULAR CELL (2004)
Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion
T Nishiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Long-term inhibition of rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice
T Hattori et al.
CIRCULATION (2004)
Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo - Effect on endothelial NAD(P)H oxidase system
M Higashi et al.
CIRCULATION RESEARCH (2003)
Rocks: Multifunctional kinases in cell behaviour
K Riento et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Actin dynamics control SRF activity by regulation of its coactivator MAL
F Miralles et al.
CELL (2003)
N-terminal short sequences of α subunits of the G12 family determine selective coupling to receptors
Y Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors
DF Chang et al.
DEVELOPMENTAL CELL (2003)
Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2
S Lange et al.
JOURNAL OF CELL SCIENCE (2002)
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus
JM Müller et al.
EMBO JOURNAL (2002)
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
M Takemoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Overexpression of stomatin depresses GLUT-1 glucose transporter activity
JZ Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
FHL2 (SLIM3) is not essential for cardiac development and function
PH Chu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)